13F HOLDINGS REPORT
5AM Venture Management, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001104659-24-089661
Total Value
$447.1M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SKYE BIOSCIENCE INC | SKYE | 10,179,505 | $81.5M | 18.24% |
| 2 | ENTRADA THERAPEUTICS INC | TRDA | 4,408,379 | $62.8M | 14.05% |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 2,610,875 | $61.0M | 13.65% |
| 4 | DIANTHUS THERAPEUTICS INC | DNTH | 1,232,965 | $31.9M | 7.14% |
| 5 | CELLDEX THERAPEUTICS INC NEW | CLDX | 497,270 | $18.4M | 4.12% |
| 6 | BIOHAVEN LTD | BHVN | 469,972 | $16.3M | 3.65% |
| 7 | TYRA BIOSCIENCES INC | TYRA | 939,298 | $15.0M | 3.36% |
| 8 | PHARVARIS N V | PHVS | 797,600 | $15.0M | 3.35% |
| 9 | PRAXIS PRECISION MEDICINES I | PRAX | 340,000 | $14.1M | 3.15% |
| 10 | ERASCA INC | ERAS | 5,405,404 | $12.8M | 2.85% |
| 11 | VIKING THERAPEUTICS INC | VKTX | 237,560 | $12.6M | 2.82% |
| 12 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 282,313 | $12.4M | 2.78% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,245,000 | $11.2M | 2.51% |
| 14 | TECTONIC THERAPEUTIC INC | TECX | 646,524 | $10.6M | 2.38% |
| 15 | VIRIDIAN THERAPEUTICS INC | VRDN | 736,595 | $9.6M | 2.14% |
| 16 | SILENCE THERAPEUTICS PLC | SLNCF | 476,200 | $9.0M | 2.02% |
| 17 | ANAPTYSBIO INC | ANABV | 357,733 | $9.0M | 2.01% |
| 18 | GH RESEARCH PLC | GHRS | 572,665 | $6.7M | 1.49% |
| 19 | COGENT BIOSCIENCES INC | COGT | 790,440 | $6.7M | 1.49% |
| 20 | VOR BIOPHARMA INC | VOR | 6,361,723 | $6.4M | 1.42% |
| 21 | SCPHARMACEUTICALS INC | 810648105 | 1,200,647 | $5.2M | 1.17% |
| 22 | RALLYBIO CORP | RLYB | 3,630,724 | $4.9M | 1.09% |
| 23 | Q32 BIO INC | QTTB | 251,994 | $4.5M | 1.01% |
| 24 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 541,666 | $3.7M | 0.83% |
| 25 | MERSANA THERAPEUTICS INC | 59045L106 | 1,305,000 | $2.6M | 0.59% |
| 26 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 490,000 | $2.0M | 0.45% |
| 27 | CIDARA THERAPEUTICS INC | 171757206 | 56,725 | $677,297 | 0.15% |
| 28 | EYEPOINT PHARMACEUTICALS INC | EYPT | 50,000 | $435,000 | 0.10% |